Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery

NCT06457100 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Rhinosinusitis
Enhanced Recovery After Surgery

Interventions

DRUG: Esmolol Injection
DRUG: Lidocaine IV

Sponsor

The Second People's Hospital of Huai'an